Investigating medication use in older adults with late-onset rheumatoid arthritis
Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritis
['FUNDING_OTHER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10932149
This study is looking at how older adults with late-onset rheumatoid arthritis are treated with certain medications, aiming to find out why they sometimes get less effective care and how to make their treatment better.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10932149 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how older adults with late-onset rheumatoid arthritis (LORA) are treated with disease modifying antirheumatic drugs (DMARDs). It aims to identify why these patients often receive less effective treatments and how their care can be improved. The study will involve gathering data on medication use, patient experiences, and health outcomes to develop better treatment strategies. By addressing the unique challenges faced by older adults with RA, the research seeks to enhance the overall management of this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who have been diagnosed with late-onset rheumatoid arthritis.
Not a fit: Patients who are younger than 65 or those without a diagnosis of rheumatoid arthritis will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better health outcomes for older adults suffering from rheumatoid arthritis.
How similar studies have performed: Previous research has shown that optimizing medication use in older adults with chronic conditions can lead to significant improvements in patient outcomes, indicating that this approach has potential for success.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEE, JIHA — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: LEE, JIHA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.